Donald M. Jensen

6.8k total citations · 1 hit paper
114 papers, 4.8k citations indexed

About

Donald M. Jensen is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Donald M. Jensen has authored 114 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hepatology, 86 papers in Epidemiology and 13 papers in Rheumatology. Recurrent topics in Donald M. Jensen's work include Hepatitis C virus research (77 papers), Liver Disease Diagnosis and Treatment (67 papers) and Hepatitis B Virus Studies (55 papers). Donald M. Jensen is often cited by papers focused on Hepatitis C virus research (77 papers), Liver Disease Diagnosis and Treatment (67 papers) and Hepatitis B Virus Studies (55 papers). Donald M. Jensen collaborates with scholars based in United States, France and Switzerland. Donald M. Jensen's co-authors include Helen S. Te, Paul J. Pockros, Adrian M. Di Bisceglie, John Hart, Scott J. Cotler, K. Rajender Reddy, Smruti R. Mohanty, Patrick Marcellin, Siddharth Verma and Michael L. Volk and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Donald M. Jensen

109 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

2014 395 citations Stefan Zeuzem, Ira M. Jacobson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald M. Jensen United States	36	3.7k	3.7k	594	386	317	114	4.8k
Akihiro Matsumoto Japan	37	3.1k 0.8×	3.3k 0.9×	353 0.6×	424 1.1×	576 1.8×	132	4.4k
Massimo Colombo Italy	29	3.2k 0.9×	3.2k 0.9×	452 0.8×	182 0.5×	265 0.8×	98	4.1k
Nathalie Boyer France	43	6.3k 1.7×	6.2k 1.7×	554 0.9×	620 1.6×	189 0.6×	115	7.1k
Savino Bruno Italy	38	5.9k 1.6×	5.7k 1.5×	625 1.1×	407 1.1×	508 1.6×	133	7.0k
Doris B. Strader United States	22	5.0k 1.4×	5.2k 1.4×	609 1.0×	422 1.1×	232 0.7×	37	6.4k
Christophe Renou France	31	2.2k 0.6×	1.8k 0.5×	583 1.0×	270 0.7×	323 1.0×	79	3.3k
Henry C. Bodenheimer United States	28	4.3k 1.2×	4.1k 1.1×	362 0.6×	555 1.4×	766 2.4×	83	5.7k
Jee‐Fu Huang Taiwan	38	3.9k 1.1×	4.0k 1.1×	279 0.5×	368 1.0×	432 1.4×	290	5.4k
Alessandra Mangia Italy	45	6.4k 1.7×	6.1k 1.7×	759 1.3×	618 1.6×	500 1.6×	202	7.7k
Jaw‐Ching Wu Taiwan	38	3.3k 0.9×	3.0k 0.8×	570 1.0×	188 0.5×	549 1.7×	145	4.9k

Countries citing papers authored by Donald M. Jensen

Since Specialization

Citations

This map shows the geographic impact of Donald M. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald M. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald M. Jensen more than expected).

Fields of papers citing papers by Donald M. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald M. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald M. Jensen. The network helps show where Donald M. Jensen may publish in the future.

Co-authorship network of co-authors of Donald M. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Donald M. Jensen. A scholar is included among the top collaborators of Donald M. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald M. Jensen. Donald M. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cotter, Thomas G. & Donald M. Jensen. (2019). <p>Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy</p>. Drug Design Development and Therapy. Volume 13. 2565–2577. 21 indexed citations

Jensen, Donald M.. (2014). Advances in combination regimens in the management of HCV infection.. PubMed Central. 2 indexed citations

Dabbouseh, Noura M. & Donald M. Jensen. (2013). Future therapies for chronic hepatitis C. Nature Reviews Gastroenterology & Hepatology. 10(5). 268–276. 32 indexed citations

Te, Helen S., Dingcai Cao, Rohit Satoskar, et al.. (2012). Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clinical Transplantation. 26(6). 826–832. 9 indexed citations

Nelson, David R., Stefan Zeuzem, Pietro Andreoné, et al.. (2012). Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients( ). Annals of Hepatology. 11(1). 15–31. 41 indexed citations

Aronsohn, Andrew & Donald M. Jensen. (2012). The long-term horizon: Patients who will remain untreated in the era of triple therapy†. Clinical Liver Disease. 1(1). 20–23. 1 indexed citations

Marcellin, Patrick, Hugo Cheinquer, Manuela Curescu, et al.. (2012). High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials. Hepatology. 56(6). 2039–2050. 79 indexed citations

Kelly, Thomas J., et al.. (2008). Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection. World Journal of Gastroenterology. 14(2). 318–318. 30 indexed citations

Nelson, David R., Gary L. Davis, Ira M. Jacobson, et al.. (2008). Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy. Clinical Gastroenterology and Hepatology. 7(4). 397–414. 11 indexed citations

10.

Kavitt, Robert T., et al.. (2008). Cerebral Edema and Hyperammonemia After Transjugular Intrahepatic Portosystemic Shunt Placement in a Cirrhotic Patient. Clinical Gastroenterology and Hepatology. 6(9). 1054–1056. 9 indexed citations

11.

Berg, Carl L., Fernando Lopes Gonçales, David Bernstein, et al.. (2006). Re‐treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon‐alpha‐2a (40 kDa) and ribavirin. Journal of Viral Hepatitis. 13(7). 435–440. 27 indexed citations

12.

Dickson, Rolland C., Norah A. Terrault, Michael B. Ishitani, et al.. (2005). Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transplantation. 12(1). 124–133. 33 indexed citations

13.

Attar, Bashar M., et al.. (2005). Serological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co‐infection. HIV Medicine. 6(6). 371–374. 2 indexed citations

14.

Sullivan, Sean D., Donald M. Jensen, David Bernstein, et al.. (2004). Cost-Effectiveness of Combination Peginterferon alpha-2a and Ribavirin Compared With Interferon alpha-2b and Ribavirin in Patients With Chronic Hepatitis C. The American Journal of Gastroenterology. 99(8). 1490–1496. 47 indexed citations

15.

Adeyemi, Oluwatoyin, et al.. (2004). Hepatitis C Treatment Eligibility in an Urban Population with and without HIV Coinfection. AIDS Patient Care and STDs. 18(4). 239–245. 34 indexed citations

16.

Cotler, Scott J., Teresa Craft, Mary W. Ferris, et al.. (2002). Induction of IL-1Ra in Resistant and Responsive Hepatitis C Patients Following Treatment with IFN-con1. Journal of Interferon & Cytokine Research. 22(5). 549–554. 9 indexed citations

17.

Cotler, Scott J., K. Rajender Reddy, Anguo Liu, et al.. (2001). An Analysis of Acute Changes in Interleukin-6 Levels After Treatment of Hepatitis C with Consensus Interferon. Journal of Interferon & Cytokine Research. 21(12). 1011–1019. 24 indexed citations

18.

Everson, Gregory T., Donald M. Jensen, John R. Craig, et al.. (1999). Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics. Hepatology. 30(1). 271–276. 49 indexed citations

19.

McChesney, Lawrence, Donald M. Jensen, Terence A.S. Matalon, et al.. (1995). Duodenal Varices: A Case Report and Review of the Literature. HPB Surgery. 9(1). 31–35. 12 indexed citations

20.

Ganger, Daniel, et al.. (1994). Spontaneous bacterial peritonitis: An update on evaluation, management, and prevention. The American Journal of Medicine. 97(2). 169–175. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact